Category: GLOBE-NEWSWIRE

Posted on

Dentsu Appoints Shirli Zelcer to Chief Data and Technology Officer

Steve Simpson joins as President, Data, Audiences and Technology; Shiva Vannavada appointed as President, Data and Technology Solutions

Shirli Zelcer

Chief Data & Technology Officer, dentsu

TOKYO, March 07, 2024 (GLOBE NEWSWIRE) — Dentsu (brand: dentsu; Head Office: Dentsu Group Inc.; Location: Tokyo; Representative: President and Global CEO Hiroshi Igarashi) today announced the appointment of Shirli Zelcer as Chief Data and Technology Officer (CDTO), sitting on dentsu’s Group Management Team. In this role, Zelcer will be responsible for all of dentsu’s client-facing data-driven, analytics and technology-enabled products and platforms, driving innovation and sustainable growth for clients.

Dentsu also announced today that Steve Simpson has been appointed as President, Data, Audiences and Technology, dentsu and Shiva Vannavada as President, Data and Technology Solutions, dentsu. Simpson will join the Global Media Practice leadership team to support the development of a winning Media Practice community that delivers continued excellence in its offering to clients, driving client growth and transformation. In his newly created role, Simpson will be responsible for the strategic planning and delivery of a globally-scaled, data-driven and technology-enabled audience platform that drives growth for clients, while Vannavada will focus on creating synergies across product and platforms, AI innovation, analytics and across Dentsu Global Services (DGS).

Zelcer brings over 20 years of experience in analytics and insights, business advisory and organizational design, AI and data science, and cloud and marketing technologies. She was most recently the Global Head of Analytics and Technology at Merkle, where she led a global division of over 5,600 practitioners across the Americas, EMEA, and APAC. In her new role at dentsu, Zelcer will be responsible to innovate the vision, roadmap, development and commercial impact of dentsu’s data and tech strategy across our three core practice areas: Media, CXM and Creative, working closer with Practice leads and Jean Lin, Global President – Global Practices, dentsu. The role will lead a newly formed team brought together from these Practice areas to drive consistency, interoperability and ultimately to deliver growth to dentsu’s clients through more unified capabilities.

Joining from Publicis, in his new role, Simpson will lead a global team of experts from across data management, identity, personalization, media activation and dynamic creative production, and partner with dentsu’s global products and platforms team to integrate and scale the platform across dentsu’s Global Practices.

Simpson will also be accountable for evolving dentsu’s global media delivery platform. Enabled by programmatic media delivery, enriched with 1st, 2nd and 3rd party data, it will leverage dentsu’s leading Merkury products suite to drive client competitiveness.

Having previously served as Global Chief Product and Technology Officer, dentsu Solutions, Vannavada’s expanded responsibilities as President, Data and Technology Solutions will include driving cross-practice and product collaboration, nurturing dentsu’s AI Connective community and leading his team to contribute to tech-enabled solutions and strategy.

“Innovation across data and technology are two of dentsu’s most critical points of differentiation, having led the market for many years in the development, adoption and application of proprietary platforms which give our clients the edge,” said Hiroshi Igarashi, President and Global CEO, dentsu. “We are very proud to appoint Shirli, Steve and Shiva into these new strategic roles which bring together our efforts across the organization, honing our capabilities and ensuring that dentsu and our clients remain at the forefront of innovation.”

The leadership of the broader Data and Tech organization at dentsu includes: Head of Product, Matt Seeley, and Sunil Rao leading Analytics, and Peter Rogers leading Data Platforms. DGS will also now report into Zelcer’s Data and Technology structure and in turn, Zelcer will report into Michael Komasinski, CEO, dentsu Americas & Global President – Data & Technology, dentsu.

Quotes:

“During her time at Merkle, Shirli brought together teams from around the world to collaborate on vital programs, ranging from data infrastructure implementation to advanced media mix modeling, personalization strategies and the development of bespoke AI solutions,” commented Michael Komasinski, CEO, dentsu Americas & Global President – Data & Technology, dentsu. “With her vast experience of successfully partnering with clients, alongside a proven ability to solve business challenges with cutting-edge technology solutions, I’m truly excited to see the impact that Shirli will have in her new expanded global role at dentsu.”

“It is a very exciting prospect to move into this new role at a time when not only is dentsu at a pivotal moment in its history, but data and technology have never evolved at a faster pace,” remarked Shirli Zelcer, Chief Data and Technology Officer, dentsu. “As a group, we have already made some big moves into AI over the last few years, but I truly see the combination of AI with dentsu proprietary and partner technologies as a major differentiator for our clients. I’m looking forward to broadening the impact I can have across dentsu and working closely with the talented leaders and teams across our tech community.”

Steve Simpson, President, Data, Audiences and Technology, dentsu, said: “I am thrilled to join dentsu at this exciting time of transformation and innovation. Data and technology are at the heart of the media industry and the integrated opportunity across Practices at dentsu in vast. I look forward to working with the talented teams throughout dentsu to build a world-class platform that will deliver value and innovation for our clients, helping them achieve their business goals.”

Shiva Vannavada, President, Data and Technology Solutions, dentsu, commented: “Since I began my journey at dentsu, we have been actively planning our future with AI and I am excited to take on this new expanded remit as we enter into what will undoubtedly be a transformational year for AI and the products and solutions we build using it. At dentsu, we don’t consider AI as a standalone technology, it is part of the fabric of our data, technology and product capabilities, ingrained into every practice and present in every agency brand. This makes us naturally more collaborative, more integrated and faster to market for our clients, and I look forward to working with teams across dentsu to break new ground in what is possible across data and tech for our clients.”

About dentsu

Dentsu is the network designed for what’s next, helping clients predict and plan for disruptive future opportunities and create new paths to growth in the sustainable economy. Taking a people-centered approach to business transformation, we use insights to connect brand, content, commerce and experience, underpinned by modern creativity. As part of Dentsu Group Inc. (Tokyo: 4324; ISIN: JP3551520004), we are headquartered in Tokyo, Japan, and our 71,000-strong employee base of dedicated professionals work across four regions (Japan, Americas, EMEA and APAC). Dentsu combines Japanese innovation with a diverse, global perspective to drive client growth and to shape society.

https://www.dentsu.com/
https://www.group.dentsu.com/en/

Contact:

Matt Cross
Phone: +442074306319
Email: matt.cross@dentsu.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cf533a57-ac1f-4ad2-87e5-340b90ec6957

GlobeNewswire Distribution ID 1000927842

Posted on

Zenas BioPharma Nomeia Patricia Allen para o Conselho Diretor

WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se tornar líder no desenvolvimento e comercialização de terapias voltadas para inflamações e imunologia, divulgou hoje a nomeação de Patricia Allen para o Conselho Diretor, onde atuará também como Presidente do Comitê de Auditoria. A Sra. Allen ingressa no Conselho Diretor da Zenas com mais de 20 anos de experiência liderando finanças, relações com investidores, desenvolvimento de negócios, recursos humanos, operações e TI em empresas globais públicas e privadas de biotecnologia.

“Estamos muito contentes com a vinda de Patty para o nosso Conselho Diretor”, disse Lonnie Moulder, Fundador e Diretor Executivo da Zenas BioPharma. “Ela liderou com sucesso funções interorganizacionais e atuou no conselho diretor de empresas privadas e públicas de biotecnologia global. Estamos prontos para as contribuições de Patty para a próxima fase do crescimento da Zenas, à medida que avançamos na nossa missão de desenvolver e comercializar terapias transformadoras baseadas em imunologia para pacientes necessitados.”

“Estou pronta para colaborar com a experiente equipe da Zenas e o Conselho Diretor, que estão ampliando uma empresa biofarmacêutica global líder em inflamação e imunologia por meio da execução disciplinada de pipeline e desenvolvimento de negócios”, disse a Sra. Allen. “A Zenas está muito empolgada com o progresso dos seus múltiplos programas clínicos que irão aprimorar as vidas das pessoas que sofrem de doenças autoimunes.”

Recentemente, a Sra. Allen atuou como Diretora Financeira da Vividion Therapeutics, de onde se aposentou recentemente. Na Vividion, ela co liderou a captação de recursos e a aquisição da empresa pela Bayer AG, durante o crescimento e avanço da empresa com vários programas em direção à clínica. Ela atua no conselho diretor e como presidente do comitê de auditoria da Deciphera Pharmaceuticals, SwanBio Therapeutics e Anokion, além de ser ex-membro do conselho e presidente do comitê de auditoria da Inversago Pharma e Yumanity Therapeutics.

Antes de ingressar na Zenas, a Sra. Allen atuou como Diretora Financeira da Zafgen, Inc. (atual Larimer Therapeutics). Anteriormente, ela foi Vice-Presidente de Finanças e Tesoureira, Diretora Financeira Principal da Alnylam Pharmaceuticals, Inc.; Diretora de Finanças da Alkermes, Inc.; e Auditora da Deloitte & Touche, LLP. Ela é formada em Administração de Empresas pelo Bryant College.

Sobre a Zenas BioPharma

A Zenas BioPharma é uma empresa biofarmacêutica mundial comprometida em se tornar líder global no desenvolvimento e comercialização de terapias voltadas para inflamações e imunologia para pacientes necessitados em todo o mundo. Com desenvolvimento clínico e operações globais, a Zenas está avançando um portfólio de terapêuticas autoimunes potencialmente diferenciadas em áreas de alta necessidade médica. Aproveitamos a experiência e a capacidade da nossa equipe de gestão executiva a das nossas existentes na indústria biofarmacêutica em busca do desenvolvimento de terapias que possam melhorar as vidas das pessoas com doenças autoimunes e raras. Para mais informação sobre a Zenas BioPharma, visite www.zenasbio.com e siga-nos no (ex Twitter ) em @ZenasBioPharma e LinkedIn.

Contato com Investidores e com a Mídia:
Argot Partners
Zenas@argotpartners.com

GlobeNewswire Distribution ID 9059519

Posted on

Patricia Allen rejoint le Conseil d’administration de Zenas BioPharma

WALTHAM, Massachusetts, 07 mars 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d’envergure mondiale déterminé à rejoindre les leaders du développement et de la commercialisation de thérapies orientées sur l’inflammation et l’immunologie, annonce la nomination de Patricia Allen à son Conseil d’administration et à la Présidence de son comité d’audit. Mme Allen rejoint le Conseil d’administration de Zenas après avoir dirigé pendant plus de 20 ans différentes divisions pour le compte de sociétés biotechnologiques internationales publiques et privées, notamment les départements des finances, relations avec les investisseurs, développement commercial, ressources humaines, opérations et informatique.

À propos de cette nomination, Lonnie Moulder, fondateur et PDG de Zenas BioPharma a déclaré : « Nous sommes ravis d’accueillir Patty au sein de notre Conseil d’administration. Elle a piloté avec succès des divisions transverses pour différentes entreprises, et a siégé au Conseil d’administration de sociétés biotechnologiques d’envergure mondiale des secteurs public et privé. Nous attendons avec impatience sa participation à la prochaine phase de croissance de Zenas, à l’heure où notre mission visant à développer et distribuer des immunothérapies modératrices du changement pour les patients qui en ont besoin prend de l’ampleur. ».

« J’ai hâte de travailler avec le concours des équipes expérimentées de Zenas et son Conseil d’administration, qui bâtissent ensemble une société biopharmaceutique internationale de premier plan axée sur des stratégies thérapeutiques orientées sur l’inflammation et l’immunologie au prix d’une exécution rigoureuse de leur pipeline et du développement commercial » observe Mme Allen, avant de poursuivre : « Le laboratoire Zenas traverse une période exaltante à l’heure où il s’efforce d’atteindre la phase clinique pour plusieurs de ses programmes dans l’objectif d’améliorer la vie des patients atteints de maladies auto-immunes ».

Actuellement retraitée, Mme Allen occupait encore très récemment la Direction des affaires financières de Vividion Therapeutics, dont elle a codirigé la levée de fonds et l’acquisition de Bayer AG, au moment où la société était en pleine croissance et faisait progresser plusieurs de ses programmes vers la phase clinique. Elle figure actuellement parmi les membres du Conseil d’administration de Deciphera Pharmaceuticals, SwanBio Therapeutics et Anokion, dont elle préside les comités d’audit, après avoir siégé aux Conseils d’administration des sociétés Inversago Pharma et Yumanity Therapeutics et en avoir également présidé les comités d’audit.

Avant son passage chez Vividion, Mme Allen pilotait la Direction financière de Zafgen, Inc., aujourd’hui Larimer Therapeutics. Avant cela, elle était vice-présidente des affaires financières, ainsi que trésorière et responsable financière principale chez Alnylam Pharmaceuticals, Inc., directrice des finances chez Alkermes, Inc., et auditrice chez Deloitte & Touche, LLP. Elle est titulaire d’une licence en gestion d’entreprises sanctionné par l’université privée américaine Bryant.

À propos de Zenas BioPharma

Zenas BioPharma est un laboratoire biopharmaceutique d’envergure mondiale déterminé à rejoindre les leaders du développement et de la commercialisation de thérapies orientées sur l’inflammation et l’immunologie pour répondre aux besoins des patients concernés partout dans le monde. À l’appui de ses capacités de développement et de ses installations de recherche clinique implantées aux quatre coins de la planète, Zenas fait progresser un ensemble de thérapies potentiellement différenciatrices ciblées sur les maladies auto-immunes dans des domaines thérapeutiques où les besoins médicaux restent insatisfaits. Son équipe de direction chevronnée et son réseau de partenaires commerciaux stimulent l’excellence opérationnelle visant à concevoir des traitements potentiellement révolutionnaires aux fins d’améliorer la qualité de vie des patients atteints de maladies auto-immunes rares. Pour en savoir plus sur Zenas BioPharma, rendez-vous sur www.zenasbio.com et suivez-nous sur X (anciennement Twitter) @ZenasBioPharma et LinkedIn.

Relations auprès des investisseurs et des médias :
Agence Argot Partners
Zenas@argotpartners.com

GlobeNewswire Distribution ID 9059519

Posted on

Stevie® Awards Anuncia Finalistas do 18th Annual Stevie® Awards de Vendas e Atendimento ao Cliente

FAIRFAX, Va., March 06, 2024 (GLOBE NEWSWIRE) —  Nomes dos finalistas do 18th annual Stevie® Awards de Vendas e Atendimento ao Cliente, uma competição internacional que homenageia a excelência em serviço ao cliente, contact centers, desenvolvimento de negócios, e vendas, foram anunciados hoje.

Um grupo diversificado de organizações e indivíduos de todo o mundo foi homenageado nos prêmios de categorias de executivos de vendas, provedores de soluções, contact centers, novos produtos e serviços, e muito mais.

As organizações Finalistas com cinco ou mais nomeações são: Allianz Services Pvt Ltd (Trivandrum, Kerala, Índia), Avetta (Lehi, UT EUA), Blackhawk Network (Pleasanton, CA, EUA), Capital Rx (Nova York, NY, EUA), CivicPlus (Manhattan, KS, EUA), Datasite (Minneapolis, MN, EUA), DHL Express Vietnam (Cidade de Ho Chi Minh, Vietnã), DHL Express (mundial), Element Electronics (Winnsboro, SC, EUA), IBM (Armonk, NY, EUA), Inspiro (Cidade de Makati, Filipinas), Intuit (Toronto, ON, Canadá), Loveholidays (Londres, Reino Unido), OpenGov (São Francisco, CA, EUA), Purpol Marketing Limited (Chippenham, Reino Unido), QNB Finansbank (Istambul, Turquia), Qualitest Group (Bridgewater, NJ, EUA), Sales Partnerships, Inc. (Broomfield, CO, EUA), SAP ( (mundial), Support Services Group, Inc. (Waco, TX, EUA), Toco Warranty (Los Angeles, CA, EUA), TransPerfect Translations (Nova York, NY, EUA), UPMC Health Plan (Pittsburgh, PA, EUA), ValueSelling Associates Inc. (Carlsbad, CA, EUA), VIZIO Inc. (Irvine, CA, EUA), VMware (Broadcom) (Palo Alto, CA, EUA), e Voya Financial (Nova York, NY, EUA).

Para uma lista completa dos Finalistas por categoria, visite www.StevieAwards.com/Sales.

Os Finalistas serão escolhidos os vencedores dos Stevie Awards Ouro, Prata e Bronze. Os rankings serão revelados durante um banquete de gala na sexta-feira, 12 de abril, no The Bellagio, em Las Vegas, Nevada. Os ingressos já estão à venda.

Os prêmios são apresentados pelo Stevie Awards, que organiza muitas das principais premiações de negócios do mundo, incluindo os prestigiados International Business Awards® e The American Business Awards®.

Mais de 2.300 indicações de organizações de cada indústria foram avaliadas na competição deste ano. Os finalistas foram escolhidos pelas pontuações médias por mais de 200 profissionais em todo o mundo em sete comissões julgadoras especializadas. As inscrições foram consideradas em mais de 60 categorias de conquistas em atendimento ao cliente e contact center, incluindo Contact Center do Ano, Prêmio de Inovação de Atendimento ao Cliente e Departamento de Atendimento ao Cliente do Ano; 60 categorias de conquistas em vendas e desenvolvimento de negócios, variando de Diretor de Vendas do Ano a Treinamento de Vendas do Ano, e Conquistas em Automação de Vendas; e categorias de reconhecimento de novos produtos e serviços, e provedores de soluções, dentre outros.

Todos os departamentos de atendimento ao cliente finalistas nomeados serão incluídos na votação do People’s Choice Stevie® Awards de Favorito em Atendimento ao Cliente. A partir de hoje até 29 de março, o público pode votar nos seus provedores favoritos de atendimento ao cliente no People’s Choice Stevie Awards de Favorito em Atendimento ao Cliente. A votação está aberta em http://peopleschoice.stevieawards.com. O indicado com mais votos em cada categoria receberá um prêmio de cristal especial People’s Choice Stevie Award. Os nomes dos vencedores do People’s Choice Stevie Awards de vários setores serão homenageados na cerimônia de premiação de gala em Las Vegas no dia 12 de abril.

As nomeações para o prêmio especial, o Prêmio Ética em Vendas das Parcerias de Vendas, também continuam em aberto até o dia 15 de março. Não há taxa de inscrição para envio de nomeações para este prêmio, que irá homenagear exemplos excepcionais de práticas éticas de vendas a partir do início de julho de 2022. Os vencedores serão anunciados e homenageado na cerimônia de 12 de abril.

Sobre os Stevie Awards
Stevie Awards são concedidos em nove programas: Stevie Awards Ásia-Pacífico, Stevie Awards Alemão, Stevie Awards Oriente Médio e África do Norte, The American Business Awards®, The International Business Awards®, Stevie Awards para Grandes Empregadoras, Stevie Awards para Mulheres Empresariais e Stevie Awards para Vendas e Atendimento ao Cliente, e os novos Stevie Awards de Excelência em Tecnologia. Os concursos Stevie Awards recebem mais de 12.000 nomeações todos os anos de empresas de mais de 70 países. Honrando empresas de todos os tipos e tamanhos, e as pessoas por trás delas, os Stevies reconhecem excelente desempenho no local de trabalho em todo o mundo. Saiba mais sobre os Stevie Awards em http://www.StevieAwards.com.

Patrocinadores do 18º Stevie Awards de Vendas e Atendimento ao Cliente incluem Sales Partnerships, Inc. Support Services Group, Inc., e ValueSelling Associates, Inc.

Contato com a Mídia:
Nina Moore
+1 (703) 547-8389
Nina@StevieAwards.com

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/d842dc2e-f7a4-40ca-a10c-1690e076d935

GlobeNewswire Distribution ID 9059418

Posted on

Les Stevie® Awards annoncent les finalistes de la 18e édition annuelle des Stevie® Awards for Sales & Customer Service

FAIRFAX, Virginie, 06 mars 2024 (GLOBE NEWSWIRE) —  Les finalistes de la 18e édition annuelle des Stevie® Awards for Sales & Customer Service, un concours international qui récompense l’excellence en matière de service client, de centres de contact, de développement commercial et de ventes, ont été dévoilés aujourd’hui.

Un groupe diversifié d’organisations et de personnes à travers le monde a été récompensé dans des catégories de prix incluant les responsables commerciaux, les prestataires de solutions, les centres de contact, les nouveaux produits et services, et bien plus encore.

Les organisations avec au moins cinq finalistes nominés comprennent Allianz Services Pvt Ltd (Trivandrum, Kerala, Inde), Avetta (Lehi, UT États-Unis), Blackhawk Network (Pleasanton, CA, États-Unis), Capital Rx (New York, NY, États-Unis), CivicPlus (Manhattan, KS, États-Unis), Datasite (Minneapolis, MN, États-Unis), DHL Express Vietnam (Ho Chi Minh-Ville, Vietnam), DHL Express (international), Element Electronics (Winnsboro, SC, États-Unis), IBM (Armonk, NY, États-Unis), Inspiro (Makati City, Philippines), Intuit (Toronto, ON, Canada), Loveholidays (Londres, Royaume-Uni), OpenGov (San Francisco, CA, États-Unis), Purpol Marketing Limited (Chippenham, Royaume-Uni), QNB Finansbank (Istanbul, Turquie), Qualitest Group (Bridgewater, NJ, États-Unis), Sales Partnerships, Inc. (Broomfield, CO, États-Unis), SAP (international), Support Services Group, Inc. (Waco, TX, États-Unis), Toco Warranty (Los Angeles, CA, États-Unis), TransPerfect Translations (New York, NY, États-Unis), UPMC Health Plan (Pittsburgh, PA, États-Unis), ValueSelling Associates Inc. (Carlsbad, CA, États-Unis), VIZIO Inc. (Irvine, CA, États-Unis), VMware (Broadcom) (Palo Alto, CA, États-Unis), et Voya Financial (New York, NY, États-Unis).

Pour obtenir la liste complète des finalistes par catégorie, rendez-vous sur : www.StevieAwards.com/Sales.

Tous les finalistes nominés recevront à l’issue de l’évènement un Stevie Award d’or, d’argent ou de bronze. Les classements seront dévoilés lors d’un banquet de gala qui se tiendra le vendredi 12 avril à l’hôtel Bellagio à Las Vegas, Nevada. Les tickets sont déjà en vente.

Les prix seront décernés par les Stevie Awards, qui organisent certains des plus grands évènements de remises de récompenses commerciales au monde, y compris les prestigieux International Business Awards® et American Business Awards®.

Plus de 2 300 candidatures provenant d’organisations de toutes tailles et de représentant presque tous les secteurs ont été évaluées lors du concours de cette année. Les finalistes ont été déterminés par des notes moyennes données par plus de 200 professionnels à travers le monde au sein de sept comités de décision spécialisés. Les candidatures ont été prises en compte pour plus de 60 catégories listant les réalisations en matière de service client et de centre de contact, notamment les prix de Centre de contact de l’année, d’Innovation en matière de service client et Service client de l’année. 60 catégories sont également consacrées aux réalisations en matière de ventes et de développement commercial, notamment les prix de Directeur des ventes de l’année, Formation commerciale de l’année, ou encore Réalisation en matière d’automatisation des ventes. D’autres catégories encore récompenseront les nouveaux produits et services et les prestataires de solutions, entre autres.

Tous les départements consacrés au service client finalistes seront inclus dans le vote pour les People’s Choice Stevie® Awards dans la catégorie Service client préféré. À partir d’aujourd’hui et jusqu’au 29 mars, le public peut voter pour ses prestataires de service client préférés dans le cadre des People’s Choice Stevie Awards, catégorie Service client préféré. Les votes sont ouverts à cette adresse : http://peopleschoice.stevieawards.com. Le candidat qui obtiendra le plus de votes dans chaque catégorie recevra un People’s Choice Stevie Award cristal spécial. Les lauréats des People’s Choice Stevie Awards dans divers secteurs seront honorés lors du gala de remise des prix qui se tiendra à Las Vegas, le 12 avril prochain.

Les candidatures pour le prix spécial d’Éthique en matière de partenariats commerciaux restent ouvertes jusqu’au 15 mars. La soumission de candidatures est gratuite pour ce prix, qui récompensera des exemples exceptionnels en matière de pratiques de vente éthiques depuis début juillet 2022. Les lauréats seront également dévoilés et honorés lors de la cérémonie du 12 avril.

À propos des Stevie Awards
Les Stevie Awards sont décernés dans le cadre de neuf programmes : les Asia-Pacific Stevie Awards, les German Stevie Awards, les Middle East & North Africa Stevie Awards, les American Business Awards®, les International Business Awards®, les Stevie Awards for Great Employers, les Stevie Awards for Women in Business, les Stevie Awards for Sales & Customer Service et le nouveau Stevie Awards for Technology Excellence. Le comité de concours des Stevie Awards reçoit tous les ans plus de 12 000 candidatures d’organisations de plus de 70 pays. En mettant à l’honneur des organisations de tous types et de toutes tailles, ainsi que les personnes qui les animent, les Stevie Awards récompensent des performances exceptionnelles sur le lieu de travail dans le monde entier. Pour en savoir plus sur les Stevie Awards, consultez le site : http://www.StevieAwards.com.

Les sponsors de la 18e édition annuelle des Stevie Awards for Sales & Customer Service incluent Sales Partnerships, Inc. Support Services Group, Inc. et ValueSelling Associates, Inc.

Contact auprès des médias :
Nina Moore
+1 (703) 547-8389
Nina@StevieAwards.com

Une photo accompagnant cette annonce est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/d842dc2e-f7a4-40ca-a10c-1690e076d935

GlobeNewswire Distribution ID 9059418

Posted on

Stevie® Awards Announce Finalists in 18th Annual Stevie® Awards for Sales & Customer Service

Stevie® Awards Announce Finalists in 18th Annual Stevie® Awards for Sales & Customer Service

Finalists in the 18th annual Stevie® Awards for Sales & Customer Service, an international competition recognizing excellence in customer service, contact centers, business development, and sales, were announced today.

FAIRFAX, Va., March 06, 2024 (GLOBE NEWSWIRE) — Finalists in the 18th annual Stevie® Awards for Sales & Customer Service, an international competition recognizing excellence in customer service, contact centers, business development, and sales, were announced today.

A diverse group of organizations and individuals worldwide have been recognized in awards categories for sales executives, solution providers, contact centers, new products and services, and more.

Organizations with five or more Finalist nominations include Allianz Services Pvt Ltd (Trivandrum, Kerala, India), Avetta (Lehi, UT USA), Blackhawk Network (Pleasanton, CA, USA), Capital Rx (New York, NY, USA), CivicPlus (Manhattan, KS, USA), Datasite (Minneapolis, MN, USA), DHL Express Vietnam (Ho Chi Minh City, Vietnam), DHL Express (worldwide), Element Electronics (Winnsboro, SC, USA), IBM (Armonk, NY, USA), Inspiro (Makati City, Philippines), Intuit (Toronto, ON, Canada), Loveholidays (London, United Kingdom), OpenGov (San Francisco, CA, USA), Purpol Marketing Limited (Chippenham, United Kingdom), QNB Finansbank (Istanbul, Turkey), Qualitest Group (Bridgewater, NJ, USA), Sales Partnerships, Inc. (Broomfield, CO, USA), SAP (worldwide), Support Services Group, Inc. (Waco, TX, USA), Toco Warranty (Los Angeles, CA, USA), TransPerfect Translations (New York, NY, USA), UPMC Health Plan (Pittsburgh, PA, USA), ValueSelling Associates Inc. (Carlsbad, CA, USA), VIZIO Inc. (Irvine, CA, USA), VMware (Broadcom) (Palo Alto, CA, USA), and Voya Financial (New York, NY, USA).

For a full list of Finalists by category, visit www.StevieAwards.com/Sales.

All Finalist nominations ultimately will be named Gold, Silver, and Bronze Stevie Award winners. The placements will be revealed during a gala banquet on Friday, April 12 at The Bellagio in Las Vegas, Nevada. Tickets are now on sale.

The awards are presented by the Stevie Awards, organizers of several of the world’s leading business awards shows including the prestigious International Business Awards® and The American Business Awards®.

More than 2,300 nominations from organizations of all sizes and in virtually every industry were evaluated in this year’s competition. Finalists were determined by the average scores of more than 200 professionals worldwide in seven specialized judging committees. Entries were considered in more than 60 categories for customer service and contact center achievements, including Contact Center of the Year, Award for Innovation in Customer Service, and Customer Service Department of the Year; 60 categories for sales and business development achievements, ranging from Sales Director of the Year to Sales Training Practice of the Year, and Achievement in Sales Automation; and categories to recognize new products and services and solution providers, among others.

All nominated finalist customer service departments will be included in voting for the People’s Choice Stevie® Awards for Favorite Customer Service. Beginning today through March 29, the general public may vote for their favorite providers of customer service in the People’s Choice Stevie Awards for Favorite Customer Service. Voting is open at http://peopleschoice.stevieawards.com. The nominee with the most votes in each category will receive a special crystal People’s Choice Stevie Award. Winners of the People’s Choice Stevie Awards in multiple industries will be honored at the awards gala in Las Vegas on April 12.

Nominations for a special prize, the Sales Partnerships Ethics in Sales Award, remain open through March 15. There are no entry fees to submit nominations for this award, which will recognize outstanding examples of ethical sales practices since the beginning of July 2022. Winners will also be announced and recognized at the April 12 ceremony.

About the Stevie Awards
Stevie Awards are conferred in nine programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Great Employers, the Stevie Awards for Women in Business, the Stevie Awards for Sales & Customer Service, and the new Stevie Awards for Technology Excellence. Stevie Awards competitions receive more than 12,000 entries annually from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

Sponsors of the 18th annual Stevie Awards for Sales & Customer Service include Sales Partnerships, Inc. Support Services Group, Inc., and ValueSelling Associates, Inc.

Media Contact:
Nina Moore
+1 (703) 547-8389
Nina@StevieAwards.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d842dc2e-f7a4-40ca-a10c-1690e076d935

GlobeNewswire Distribution ID 9058607

Posted on

Zenas BioPharma Appoints Patricia Allen to its Board of Directors

WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies, today announced the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chairperson of the Audit Committee. Ms. Allen joins the Zenas Board of Directors with over 20 years of experience leading finance, investor relations, business development, human resources, operations and IT at global public and private biotechnology companies.

“We are pleased to welcome Patty to our Board of Directors,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma. “She has successfully led cross-organizational functions and served on the board of directors of both private and public global biotechnology companies. We look forward to Patty’s contributions to the next phase of Zenas’ growth as we advance our mission to develop and commercialize transformative immunology-based therapies for patients in need.”

“I look forward to collaborating with the experienced Zenas team and Board of Directors, who are building a leading of inflammation and immunology-focused global biopharmaceutical company through disciplined pipeline execution and business development,” said Ms. Allen. “This is an exciting time for Zenas as they seek to progress multiple programs through the clinic to ultimately improve the lives of those living with autoimmune diseases.”

Ms. Allen most recently served as the Chief Financial Officer at Vividion Therapeutics, from where she recently retired. While at Vividion, she co-led led fundraising and the company’s acquisition by Bayer AG, as the company grew and advanced multiple programs towards the clinic. She currently serves on the board of directors and as chair of the audit committee of Deciphera Pharmaceuticals, SwanBio Therapeutics and Anokion, in addition to holding past board member and audit committee chair roles at Inversago Pharma and Yumanity Therapeutics.

Prior to Vividion, Ms. Allen was the Chief Financial Officer at Zafgen, Inc. (now Larimer Therapeutics). Earlier, she was Vice President of Finance and Treasurer, Principal Financial Officer of Alnylam Pharmaceuticals, Inc.; Director of Finance at Alkermes, Inc.; and Auditor at Deloitte & Touche, LLP. She received a B.S. in Business Administration from Bryant College.

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies for patients in need around the world. With clinical development capabilities and operations globally, Zenas is advancing a portfolio of potentially differentiated autoimmune therapeutics in areas of high unmet medical need. We leverage the experience and capabilities of our executive management team and our established networks throughout the biopharmaceutical industry as we seek to develop therapies that can improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on X (formerly Twitter) at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Argot Partners
Zenas@argotpartners.com

GlobeNewswire Distribution ID 9058707